BHEL ‘buy’ recommendations from analysts are at the highest in over a decade

Share it

While CLSA expects BHEL shares to fall to levels of ₹166, Morgan Stanley sees its price target to be more than double of CLSA.

Leave a Comment

Your email address will not be published. Required fields are marked *